OR2W3 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of OR2W3, a member of the olfactory receptor (OR) family, which belongs to the G-protein-coupled receptor (GPCR) superfamily. OR2W3, like other olfactory receptors, plays a vital role in the detection of odorant molecules in the nasal epithelium. When an odorant binds to OR2W3, it triggers a signal transduction pathway involving the activation of G-proteins, leading to a cascade of intracellular events that ultimately result in the perception of smell. OR2W3 is highly specialized for detecting specific odorants and contributes to the complex system that allows organisms to discriminate between a wide range of chemical compounds in their environment. By inhibiting OR2W3, these inhibitors disrupt the normal function of this receptor, preventing it from activating its signaling pathway and impairing its role in olfaction.
Beyond their involvement in olfaction, OR2W3 inhibitors are useful in studying the broader functions of olfactory receptors, which are increasingly recognized for their roles in non-olfactory tissues. These receptors, including OR2W3, have been found in various tissues throughout the body, where they may participate in diverse cellular processes such as cell signaling, metabolic regulation, and tissue homeostasis. Inhibitors of OR2W3 provide researchers with the ability to explore how the inhibition of this receptor impacts both sensory and non-sensory functions. By blocking OR2W3, researchers can study the molecular mechanisms that regulate olfactory receptor activity, as well as investigate how these receptors contribute to broader physiological processes beyond their traditional role in detecting odorants. This research expands our understanding of the multifaceted roles played by olfactory receptors in various biological contexts.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil inhibits OR2W3 by blocking L-type calcium channels, disrupting calcium-mediated signal transduction pathways essential for olfactory receptor neuron activation, leading to inhibition of OR2W3 function. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
Ketoconazole inhibits OR2W3 by altering cell membrane fluidity and signaling pathways, indirectly affecting the receptor's ability to respond to olfactory stimuli by disrupting normal cellular processes. | ||||||
Ibuprofen | 15687-27-1 | sc-200534 sc-200534A | 1 g 5 g | $53.00 $88.00 | 6 | |
Ibuprofen inhibits OR2W3 by modulating prostaglandin synthesis, indirectly affecting signal transduction pathways associated with inflammation that could influence OR2W3 activity. | ||||||
1-Adamantylamine | 768-94-5 | sc-251475 sc-251475A | 1 g 25 g | $39.00 $147.00 | ||
1-Adamantylamine inhibits OR2W3 by blocking NMDA receptors, potentially affecting the olfactory bulb's neurotransmission and indirectly inhibiting OR2W3's signal transduction capabilities. | ||||||
Lidocaine | 137-58-6 | sc-204056 sc-204056A | 50 mg 1 g | $51.00 $131.00 | ||
Lidocaine inhibits OR2W3 by blocking sodium channels on olfactory receptor neurons, preventing action potential initiation and propagation crucial for OR2W3 function. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
Diltiazem inhibits OR2W3 by blocking L-type calcium channels, similar to verapamil, disrupting the calcium-dependent signaling pathways necessary for OR2W3 activation. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine inhibits OR2W3 by selectively blocking L-type calcium channels, thereby disrupting calcium-mediated signal transduction pathways that are essential for the receptor's function. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine inhibits OR2W3 by altering membrane fluidity and blocking dopamine receptors, which may indirectly influence the signal transduction pathways associated with olfactory receptors. | ||||||
Quinine | 130-95-0 | sc-212616 sc-212616A sc-212616B sc-212616C sc-212616D | 1 g 5 g 10 g 25 g 50 g | $79.00 $104.00 $166.00 $354.00 $572.00 | 1 | |
Quinine inhibits OR2W3 by blocking potassium channels critical for the repolarization phase of olfactory receptor neuron action potentials, thereby disrupting the signal transduction process. | ||||||
Capsazepine | 138977-28-3 | sc-201098 sc-201098A | 5 mg 25 mg | $148.00 $459.00 | 11 | |
Capsazepine inhibits OR2W3 by blocking TRPV1 channels, potentially disrupting ion flux and neuronal excitability crucial for the activation of olfactory signal transduction pathways. | ||||||